In a rat model of asthma, oral pretreatment with NAC reduced airway hyperresponsiveness, decreased lipid peroxidation and oxidized glutathione levels, and lowered the TNFα, inducible nitric oxide (NO) synthase, ICAM-1, and mucin MUC5AC expressions [138]. Here, MUC5AC is linked to airway hyperresponsiveness.